Human tRNASec associates with HeLa membranes, cell lipid liposomes, and synthetic lipid bilayers

  1. Michael Yarus1,3
  1. 1Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado 80309, USA
  2. 2Department of Biotechnology and Molecular Biology, University of Opole, 45-032 Opole, Poland

    Abstract

    We have shown previously that simple RNA structures bind pure phospholipid liposomes. However, binding of bona fide cellular RNAs under physiological ionic conditions is shown here for the first time. Human tRNASec contains a hydrophobic anticodon-loop modification: N6-isopentenyladenosine (i6A) adjacent to its anticodon. Using a highly specific double-probe hybridization assay, we show mature human tRNASec specifically retained in HeLa intermediate-density membranes. Further, isolated human tRNASec rebinds to liposomes from isolated HeLa membrane lipids, to a much greater extent than an unmodified tRNASec transcript. To better define this affinity, experiments with pure lipids show that liposomes forming rafts or including positively charged sphingosine, or particularly both together, exhibit increased tRNASec binding. Thus tRNASec residence on membranes is determined by several factors, such as hydrophobic modification (likely isopentenylation of tRNASec), lipid structure (particularly lipid rafts), or sphingosine at a physiological concentration in rafted membranes. From prior work, RNA structure and ionic conditions also appear important. tRNASec dissociation from HeLa liposomes implies a mean membrane residence of 7.6 min at 24°C (t½ = 5.3 min). Clearly RNA with a 5-carbon hydrophobic modification binds HeLa membranes, probably favoring raft domains containing specific lipids, for times sufficient to alter biological fates.

    Keywords

    Footnotes

    • Received July 3, 2012.
    • Accepted September 14, 2012.

    Freely available online through the RNA Open Access option.

    Articles citing this article

    | Table of Contents
    OPEN ACCESS ARTICLE